{"id":"7db4bc18-6d8d-468e-8b0b-d8d2e8306480","arxiv_id":"2505.06377","paper_version":1,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":5.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":8,"one_line_summary":"In a simulated rock-paper-scissors ecosystem with two interfering diseases, antagonistic coinfection shrinks spatial domains, lowers infection risk, and, combined with reduced mobility, raises life expectancy by up to 54%.","lead":"This paper uses computer simulations of a rock-paper-scissors ecosystem to show that when two diseases interfere with each other in coinfected hosts, populations grow denser and individuals get infected less often. Adding mobility restrictions on top can extend simulated lifespans by up to 54%.","discovery_kind":"extension","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The 54% life-expectancy gain is computed from an ill-defined survival-time integral; as written, tau = integral(1-omega)dt diverges, and the reported ratio is not reproducible from the stated method.","rationale":"The paper's qualitative findings are plausible and the simulation framework is standard, so rejection is not warranted. However, the central quantitative claim, the 54% life-expectancy increase, rests on a quantity whose definition in Sec. 6.3 is mathematically inconsistent: integrating a constant survival probability over an infinite horizon diverges. The reader identified the lack of sensitivity analysis as the weakest assumption, which is a genuine limitation, but an internal inconsistency in the computation of the headline number is more immediately load-bearing. A clarifying revision or a small supplementary calculation (omega values or raw survival curves) would settle whether the 54% is a real model output or an artifact of the estimator. Since this can be addressed without changing the model or the qualitative conclusions, conditional acceptance remains the appropriate verdict, with the clarification as a condition.","tokens_in":13151,"tokens_out":8596,"duration_ms":84143,"concrete_test":"Run the same parameter set (S=R=1, M=3, T=4, C=mu=0.1, gamma=1) with a fixed random seed. Record omega(nu) for nu=0 and nu=1 over 5000 generations, or track individual lifetimes cohort-by-cohort. Compute tau_tilde = omega(0)/omega(1)-1 and compare with the 54% reported in Fig. 10. Independently compute the empirical mean lifetime directly from the cohort data. If both estimates differ from 54% by more than a few percentage points, the headline result depends on the ambiguous integral in Sec. 6.3 rather than on the model dynamics.","verdict_should_be":"UNCHANGED","load_bearing_attack":"Section 6.3 defines expected survival time as tau = integral_0^inf S_i dt with S_i(nu) = 1 - omega(nu), where omega is the per-generation death probability. Since omega is constant in the integrand, this integral diverges for every nu < 1 (and even at nu = 1 unless omega = 0). The standard discrete-time expected lifetime is tau = sum_{t>=0} (1-omega)^t = 1/omega, or, in continuous time, tau = 1/omega for an exponential lifetime. Under either convention, tau_tilde = (tau(nu)-tau(0))/tau(0) equals omega(0)/omega(nu)-1 (or close to it). The paper reports tau_tilde ~ 54% at gamma=1, nu=1, which would require omega(1) ~ 0.65 omega(0), a 35% reduction in death probability. But the manuscript reports no direct values of omega(nu), no raw survival curves, and no code, so the reader cannot tell whether Fig. 10 was produced with tau = 1/omega, with the divergent integral, or with some other estimator. If the integral was instead evaluated only over the 5000-generation simulation window, tau would depend on an arbitrary cutoff and the 54% would not be a true expectation. Because this number is the paper's central quantitative claim, the method must be clarified before the headline result can be accepted. The reader's concern about the single fixed parameter regime is valid but secondary; it is an external-robustness limitation, whereas the survival-time definition is an internal consistency issue.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper studies a spatial stochastic rock-paper-scissors model with two concurrent pathogens that act antagonistically in coinfected hosts, reducing their disease-induced mortality. Using lattice simulations, the authors analyze spatial pattern formation, cure probability, infection risk, species density, and the impact of mobility restrictions on infection risk, selection risk, and expected survival time. The main quantitative claims are that antagonistic coinfection reduces infection risk by up to 26%, increases species density by up to 11%, and that combining total antagonism with full mobility restriction increases expected lifetime by approximately 54% (Fig. 10).","tokens_in":13524,"tokens_out":8784,"duration_ms":70916,"significance":"If the results hold, this would be a useful demonstration of how antagonistic coinfection and behavioral mobility restriction interact in a well-studied spatial competition model, with potential implications for ecological and public-health interventions. The simulation methodology is standard and transparent (100-run ensembles, standard deviations, clear interaction rules), and the study covers both global and uneven antagonism. However, the central survival-time claim is currently not reproducible because the definition of tau in Sec. 6.3 is mathematically ill-posed, and there is an internal contradiction in the reported selection-risk trend. These issues must be fixed before the paper's main contribution can be assessed.","major_comments":[{"comment":"The definition of expected survival time tau = integral_0^inf S_i dt with S_i(nu) = 1 - omega(nu) is mathematically ill-posed, because omega(nu) is a constant per-generation death probability, making the integrand constant and the integral divergent for any omega(nu) < 1. If the integral was instead evaluated only over the 5000-generation simulation window, the result depends on an arbitrary cutoff and is not an expected lifetime. The standard discrete-time estimator is tau = sum_{t>=0} (1-omega)^t = 1/omega (or tau = 1/omega in continuous time), under which the relative change satisfies tau_tilde = omega(0)/omega(nu) - 1; the reported 54% gain at gamma=1, nu=1 would then imply omega(1)/omega(0) ~ 0.65, a 35% reduction in per-generation death probability. Since the authors do not report omega(0), omega(1), or raw survival curves, Fig. 10 and the headline 54% claim are not reproducible from the stated methods. Please clarify the estimator actually used and report the underlying omega values or survival curves.","section":"Section 6.3"},{"comment":"The sentence 'we observe that the effectiveness of mobility restriction becomes more pronounced as the level of antagonism in coinfected hosts' disease mortality decreases' is directly contradicted by the numbers in the same paragraph: at nu = 0.8, the reduction in selection risk is 17.5% for gamma=0.0, 21.5% for gamma=0.5, and 22.5% for gamma=1.0, i.e., the reduction increases with antagonism, not decreases. This internal inconsistency undermines the stated conclusion about the interplay between mobility restriction and antagonism for selection risk; the text and the interpretation should be corrected.","section":"Section 6.2"},{"comment":"All quantitative results are obtained for a single parameter regime, S=R=1, M=3, T=4, C=mu=0.1, with gamma and nu varied. The reported magnitudes (e.g., 26% infection-risk reduction, 11% density increase, 54% survival-time gain) are therefore point estimates in this regime. Since the abstract and conclusions present these percentages without caveats, please provide at least a limited sensitivity analysis (e.g., varying T or mu over an order of magnitude, or varying M) to show that the qualitative conclusions, and ideally the reported ranges, are robust. At minimum, state explicitly that the percentages are conditional on this fixed parameter set.","section":"Section 5 (Figs. 6-7) and Section 6.3 (Fig. 10)"}],"minor_comments":[{"comment":"The sentence 'the maximum rise in cure probability is approximately 5.42% for uneven antagonism and 5.95% for global antagonism, as appear in Fig. 5 for gamma = 1' is ambiguous and appears inconsistent with the later relative increases of 6.69% and 17.52% (the absolute values at gamma=1 would imply a baseline near 5.1%, below the y-axis range of Fig. 5). Please clarify whether these numbers are absolute cure probabilities at gamma=1 or absolute increases, and reconcile them with the figure.","section":"Section 5, around Fig. 5"},{"comment":"The symbol S_i is used both for the spectral density in Eq. (3) and for the survival probability in Sec. 6.3; please use distinct notation.","section":"Section 4, Eq. (3), and Section 6.3"},{"comment":"Typographical issues include 'grid sites with 500 2' instead of '500^2' (Secs. 4, 5, 6.1-6.3), 'from from' in Sec. 4, 'simulations parameters' in Sec. 3, and 'Fig.10' missing a space in Sec. 6.3.","section":"Sections 3-6"},{"comment":"The symbol xi_0 is used in the definition of xi_tilde but chi_0 is the notation introduced for the baseline infection risk; please standardize the notation.","section":"Section 6.1"}],"recommendation":"major_revision","confidential_remarks":"The manuscript appears to be a template submission with 'Preprint submitted to Journal of LATEX Templates' on the first page; the authors should ensure the final version is formatted for the target journal. The internal inconsistencies (Sec. 6.2) suggest the text has not been fully checked against the figures. The paper relies heavily on the authors' own prior work (Refs. 28, 37, 38, 39), which is understandable given the model lineage."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Julian,\n\nQuick take: this is a workmanlike extension of the authors' own spatial RPS coinfection program, and the qualitative story holds up. Antagonism reduces infection risk, increases species density, and shrinks spatial domains. What's genuinely new is the antagonistic (rather than synergistic) coinfection scenario and its coupling to mobility restriction. The simulations look standard: 100 runs, error bars, clear step-by-step definitions of the diagnostics. On that level, the paper is fine.\n\nThe soft spots are concentrated in Section 6, and they are not cosmetic. The definition of expected survival time in Sec. 6.3 is tau = integral_0^infty S_i dt with S_i = 1 - omega, where omega is a per-generation death probability. If omega is constant, that integral diverges. The authors must have intended a discrete sum, tau = sum (1-omega)^t = 1/omega, or a finite-window estimator, but they don't say which, and they don't report omega(nu) or any raw survival curves. Since the 54% life-expectancy claim is the paper's headline, this needs to be fixed before the number means anything.\n\nThere is also a direct internal contradiction in Sec. 6.2: the text says mobility-restriction effectiveness decreases with antagonism, but the immediately following numbers (17.5%, 21.5%, 22.5% for gamma = 0, 0.5, 1) show it increasing. That's a simple wording slip, but it's confusing.\n\nMore generally, everything is computed in one parameter regime (S=R=1, M=3, T=4, C=mu=0.1), with no sensitivity analysis and no code or data. So the specific percentages (26%, 11%, 54%) are illustrations of the model, not robust empirical predictions. The qualitative claims are probably right, but the quantitative ones are not yet supported.\n\nThe citation pattern is heavily self-referential but not dishonest: the framework is genuinely the authors' own. The abstract and intro are clear; the limitations are not discussed, which is a minor omission.\n\nBottom line: this deserves a serious referee, but it needs a substantial revision before the survival-time result can be accepted. I'd ask the authors to provide the exact estimator, raw survival probabilities, and corrected text. As is, I wouldn't cite the 54% figure.\n\nBest,\n[Your name]","headline":"Antagonistic coinfection with mobility restriction is a sensible new parameter regime in the authors' established RPS framework, but the headline 54% survival-time gain is not reproducible as written because the defining integral diverges.","tokens_in":14065,"tokens_out":3115,"would_cite":false,"duration_ms":28233,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"In a spatial rock-paper-scissors model, antagonistic coinfection and mobility restriction together raise organism life expectancy by about 54%.","keywords":["antagonistic coinfection","rock-paper-scissors model","concurrent epidemics","spatial stochastic simulations","mobility restriction","infection risk","life expectancy","cyclic competition"],"falsifier":"Run the same simulations with antagonism also modifying transmission or cure probabilities, or with a different base parameter set such as small $M$ or $T$ much larger than $S$; if the roughly 54% lifetime gain at $\\gamma=\\nu=1$ does not persist or reverses sign, the central quantitative claim is regime-specific rather than general.","tokens_in":12952,"feed_emoji":"🦠","tokens_out":5050,"duration_ms":49326,"temperature":0.7,"pith_summary":"This paper argues that when two epidemics spread through a cyclically competing population and coinfection is antagonistic, meaning each pathogen suppresses the lethal effect of the other, the population as a whole becomes safer: healthy hosts are less likely to be infected, species densities rise, and spatial domains shrink. It further claims that restricting individual mobility multiplies this protection. At full antagonism and full mobility restriction, expected lifetime increases by roughly 54% relative to unrestricted populations. The paper frames this as a step toward designing interventions for managing concurrent epidemics in spatially structured ecological systems.","feed_headline":"Antagonistic coinfection plus restricted mobility raises lifespan 54%","feed_subtitle":"In spatial rock-paper-scissors epidemics, antagonistic coinfections plus reduced movement cut infection risk and lift survival.","key_machinery":"The central object is a stochastic spatial rock-paper-scissors model on a square lattice with three cyclically competing species and two independent pathogens. Antagonism enters only through the death step: coinfected hosts die from disease $i$ with probability rescaled by $(1-\\gamma_i)$, so $\\gamma_i=1$ means a coinfected host never dies of that disease; mobility restriction $\\nu$ is the probability that a randomly chosen move is refused. The metric carrying the conclusion is expected survival time $\\tau=\\int_0^\\infty S(t)\\,dt$, where $S=1-\\omega$ and $\\omega$ is the probability of dying in a generation from either selection or disease. This lets the paper separate infection risk, selection risk, and lifetime.","core_discovery":"The central discovery is quantitative: in stochastic simulations of cyclic competition with two pathogens, rescaling coinfected-host mortality by antagonistic factors $\\gamma_1,\\gamma_2\\in[0,1]$ lowers infection risk by up to about 26% and raises species density by up to about 11% at $\\gamma_1=\\gamma_2=1$, while adding a mobility-restriction factor $\\nu$ reduces infection risk further and lifts expected lifetime by about 54% at $\\gamma=1,\\nu=1$. The authors attribute these gains to coinfected hosts living longer, which increases cure probabilities and leaves more healthy organisms arising from selection-created empty sites. They also report that global antagonism outperforms uneven antagonism by roughly a factor of two in species-density gain, and that the spatial autocorrelation length falls by about 10% as antagonism goes from zero to total.","pith_inferences":["If antagonism also altered transmission or recovery rates instead of only mortality, the reported percentages would likely change; the model's fixed parameter regime is a limitation the paper does not address.","A testable public-health hypothesis follows: in populations where coinfecting pathogens suppress each other's virulence, movement restrictions may yield larger survival benefits than in single-pathogen settings.","One could test robustness by sweeping $S,R,M,T,C,\\mu$; the 54% figure is a single-regime result, and the qualitative claim would be stronger if the ordering of lifetime gains persists across regimes."],"forward_implications":["At full antagonism but no mobility change, infection risk falls by about 26% and species density rises by about 11%, so antagonistic pathogen interactions alone may protect host populations.","Mobility restriction alone raises expected lifetime by about 12.5% at $\\gamma=0$, while with total antagonism the gain grows to about 54%, so the two effects compound rather than merely add.","Reducing mobility by 80% cuts selection risk by about 17.5% to 22.5% depending on antagonism level, meaning movement restriction protects against competitive elimination as well as infection.","Spatial domains become finer as antagonism strengthens, with the characteristic length scale falling about 10%, so cyclic coexistence fragments into smaller patches."],"supporting_citations":[{"why":"Supplies the baseline two-epidemic rock-paper-scissors model that this paper modifies from synergistic to antagonistic coinfection.","marker":"[28]"},{"why":"Provides the mobility-restriction modeling approach that Section 6 extends to the antagonistic coinfection case.","marker":"[37]"},{"why":"Defines the non-conserved cyclic-competition dynamics underlying the simulations.","marker":"[36]"},{"why":"Supplies the selection-risk definition used to compute the mobility-restriction effects.","marker":"[39]"},{"why":"Establishes the role of mobility in rock-paper-scissors biodiversity that motivates the mobility restriction analysis.","marker":"[6]"}],"fun_headline_variants":["Antagonistic coinfection plus mobility caps raise lifespan 54%","Coinfection antagonism and movement restrictions extend lifespan 54%","Reducing mobility in antagonistic coinfections raises survival by 54%","Antagonistic coinfection and travel limits lengthen life 54% in epidemics"],"cache_read_input_tokens":3200,"weakest_assumption_plain":"The results depend on antagonism acting only through a multiplicative reduction of coinfected-host disease mortality, with transmission, cure, selection, reproduction, and the base rates $S=R=1$, $M=3$, $T=4$, $C=\\mu=0.1$ held fixed; if antagonism alters other steps, or the base rates differ, the reported percentages may not carry over.","fun_headline_variants_meta":{"raw":{"variants":["Antagonistic coinfection plus mobility caps raise lifespan 54%","Coinfection antagonism and movement restrictions extend lifespan 54%","Reducing mobility in antagonistic coinfections raises survival by 54%","Antagonistic coinfection and travel limits lengthen life 54% in epidemics"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.001178,"raw_usage":{"total_tokens":4861,"prompt_tokens":931,"completion_tokens":3930,"prompt_tokens_details":{"cached_tokens":384},"prompt_cache_hit_tokens":384,"prompt_cache_miss_tokens":547,"completion_tokens_details":{"reasoning_tokens":3851}},"tokens_in":547,"tokens_out":3930,"duration_ms":29669,"temperature":1.0,"reasoning_tokens":3851,"cache_read_input_tokens":384,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-15T22:44:35.362626+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Run the same simulations with antagonism also modifying transmission or cure probabilities, or with a different base parameter set such as small $M$ or $T$ much larger than $S$; if the roughly 54% lifetime gain at $\\gamma=\\nu=1$ does not persist or reverses sign, the central quantitative claim is regime-specific rather than general.","supporting_citations":[{"cited_title":"Menezes, E","cited_arxiv_id":null,"evidence_quote":"Supplies the baseline two-epidemic rock-paper-scissors model that this paper modifies from synergistic to antagonistic coinfection."},{"cited_title":"Menezes, S","cited_arxiv_id":null,"evidence_quote":"Provides the mobility-restriction modeling approach that Section 6 extends to the antagonistic coinfection case."},{"cited_title":"Moura, J","cited_arxiv_id":null,"evidence_quote":"Supplies the selection-risk definition used to compute the mobility-restriction effects."}],"review_version":1}